Funded Tech Companies
Quell Therapeutics
Quell Therapeutics is a biopharmaceutical company, based in London. Venture capital investment was provided by Fidelity Management & Research Company, Tekla Capital Management and JEITO.
Company Overview
Company Name
Quell Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Translation & Innovation Hub 84 Wood Ln.
London, W12 OBZ
UK
London, W12 OBZ
UK
Phone
Website
Email Address
Company Background Information
Overview
At Quell we seek to deliver truly innovative, life-changing therapies for our patients. Our vision as a company is to build a major global biopharmaceutical company bringing transformational and valued therapies for a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation, based on modular engineered Tregs.
Last Transaction
11/30/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Company Investors
- Fidelity Management & Research Company
- Tekla Capital Management
- JEITO (Rachel Mears)
- Syncona (Martin Murphy)
- Point72 Ventures
- British Patient Capital
- SV Health Investors (Houman Ashrafian)
- Ridgeback Capital (Jeffrey Long-McGie)
- Monashee Investment Management
- Janus Henderson Investors
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs